Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05877430 |
| Title | Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | CJ Bioscience, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, Irvine | RECRUITING | Irvine | California | 92697 | United States | Details |
| University of Pittsburgh | NOT_YET_RECRUITING | Pittsburgh | Pennsylvania | 15260 | United States | Details |
| Samsung Medical Center | RECRUITING | Seoul | Korea, Republic of | Details | ||
| Severance Hospital | RECRUITING | Seoul | Korea, Republic of | Details |